INTERNATIONAL PATENT: TIANJIN UNIVERSITY FILES APPLICATION FOR "USE OF A FKBP51 INHIBITOR IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING OR PREVENTING DISEASES CAUSED BY MITOCHONDRIAL ABNORMALITIES"

GENEVA, Oct. 4 -- TIANJIN UNIVERSITY (92 Weijin Rd, Building 15Nankai District, Tianjin 300072) filed a patent application (PCT/CN2025/085699) for "USE OF A FKBP51 INHIBITOR IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING OR PREVENTING DISEASES CAUSED BY MITOCHONDRIAL ABNORMALITIES" on Mar 28, 2025. With publication no. WO/2025/201510, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MI, Li-Zhi (92 Weijin Rd, Building 15Nankai District, Tianjin 300072), QIN, Xiaohong (92 Weijin Rd, Building 15Nankai District, Tianjin 30007...